Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
about
Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of protein kinase C ...... mbined therapeutic strategies.
@en
Inhibition of protein kinase C ...... mbined therapeutic strategies.
@nl
type
label
Inhibition of protein kinase C ...... mbined therapeutic strategies.
@en
Inhibition of protein kinase C ...... mbined therapeutic strategies.
@nl
prefLabel
Inhibition of protein kinase C ...... mbined therapeutic strategies.
@en
Inhibition of protein kinase C ...... mbined therapeutic strategies.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of protein kinase C ...... ombined therapeutic strategies
@en
P2093
Arianna Donella-Deana
Lorenzo A Pinna
Luca Cesaro
Valentina Salizzato
P2860
P304
18204-18218
P356
10.18632/ONCOTARGET.7569
P407
P577
2016-04-01T00:00:00Z